Molecular and Genomic Pathology

The Division of Molecular and Genomic Pathology is led by Vice Chair, Mark A. Rubin, MD. This laboratory offers molecular pathology services including a CLIA-approved 50-gene panel next-generation sequencing test, tests for T and B cell clonality, transactions in chronic myeloid leukemia and acute promyelocytic leukemia. The laboratory also tests for lymphoma associated viruses.